Retriever Medical, Inc.

Retriever Medical is developing ClotHound to remove blood clots in DVT and PE, starting with a DVT device on a planned 510(k) pathway.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Las Vegas, NV, USA
  • Currency USD
  • Founded May 2020
  • Employees 2
  • Incorporation Type C-corp
  • Website rtvmed.com

Company Summary

Retriever Medical is developing ClotHound, a disposable mechanical thrombectomy system for DVT and PE. We plan to seek initial 510(k) clearance for DVT and sell single-use devices for hospital procedures. We are raising an $11 million Series A to fund development, testing, regulatory work and commercialization preparation.

Team

  • Ben Bobo
    Co-Founder & CEO

    Ben Bobo, Co-Founder and CEO of Retriever Medical, brings 30+ years of medtech leadership across product development, fundraising, commercialization and M&A. He has raised more than $48 million, achieved two exits and holds 12 issued patents. His expertise spans building teams, advancing medical devices from concept toward market and developing strategic partnerships.

  • Hieu Le
    VP R&D

    Hieu Le, VP of R&D at Retriever Medical, brings expertise in vascular device engineering and the design and development of interventional platforms. His experience in product development and systems engineering supports ClotHound’s technical development, testing and progression toward manufacturing readiness.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free